• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Australia’s Estia Health Surges After $517.7 mln Bid from Bain Capital

Share:

March 27, 2023

On Friday, Estia Health Ltd, an Australian aged-care provider, announced that it has received a non-binding buyout proposal from US private investment firm Bain Capital for A$775.1 million ($517.77 million). The proposal offers A$3.00 cash per share, which represents a 28.2% premium to Estia’s last close. Estia’s board is evaluating the proposal to assess whether it is in the best interests of shareholders to engage with Bain Capital. Following the news, Estia’s shares surged by as much as 21.4% to A$2.84, the highest level since November 2019. The company had posted a net loss from ordinary activities after tax attributable for the six months ended Dec. 31 of A$25.3 million, compared to a loss of A$8.1 million a year prior.

Australian aged-care provider Estia Health Ltd (EHE.AX) said on Friday it received a non-binding buyout proposal from U.S. private investment firm Bain Capital for A$775.1 million ($517.77 million), sending its shares to an over 3-year high.

The A$3.00 cash per share proposal, which is at a 28.2% premium to Estia’s last close, is among the latest proposals by a private equity firm since last year amid increasing merger and acquisition activity in Australia.

The board of Estia Health is considering the indicative proposal to assess whether it is in the best interests of shareholders to engage with Bain Capital, the company said in a statement.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Shares of the Sydney-based company surged as much as 21.4% to A$2.84, their highest since November 2019. It was also on track to post its biggest jump in more than two years.

Local media had reported on Thursday that a potential acquirer was buying shares in the company based on its volume over the past two days.

On Friday, Estia said it is not aware of the identity of the party or parties who have acquired shares over the preceding two days.

With reference to the local media report, brokerage RBC said it had a positive outlook for the aged care sector on improving occupancy rates, dissipating COVID impacts and smaller providers exiting the market.

Estia last month posted net loss from ordinary activities after tax attributable for six months ended Dec. 31 of A$25.3 million, compared to a loss of A$8.1 million a year prior.

In April last year, EML Payments (EML.AX) was in talks with Bain Capital for a potential buyout, but the company said the talks had ceased without an agreed deal.

Source: Health.Economictimes

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • MedPlast closes deal, rebrands as ViantMedPlast closes deal, rebrands as Viant
  • Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory BusinessLabcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
  • Astellas Completes Acquisition of Audentes TherapeuticsAstellas Completes Acquisition of Audentes Therapeutics
  • Novartis Plans Sandoz Spin-off Around Oct. 4, Proposes Share.Novartis Plans Sandoz Spin-off Around Oct. 4, Proposes Share.
  • Millstone Medical Outsourcing Completes Acquisition of Ethide LabsMillstone Medical Outsourcing Completes Acquisition of Ethide Labs
  • Life Biosciences : Acquires Lua, Pioneering AI-Driven Healthcare PlatformLife Biosciences : Acquires Lua, Pioneering AI-Driven Healthcare Platform
  • Danaher to acquire Abcam for $24.00 per ShareDanaher to acquire Abcam for $24.00 per Share
  • Unchained Labs gets teed up for the future, snags $50 million debt facility with Silicon Valley BankUnchained Labs gets teed up for the future, snags $50 million debt facility with Silicon Valley Bank

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications